We are live on ! Find out more
TOIIW

The Oncology Institute Warrant

Delisted

TOIIW was delisted on the 31st of July, 2026.

14 hedge funds and large institutions have $19.2K invested in The Oncology Institute Warrant in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.33% more ownership

Funds ownership: 3.44%4.78% (+1.3%)

7% less funds holding

Funds holding: 1514 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

63% less capital invested

Capital invested by funds: $52K → $19.2K (-$32.8K)

83% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 6

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
6
Closed
2
Calls
$1K
Puts
Net Calls
+$1K
Net Calls Change
-$34K

TOIIW Hedge Fund Activity: Q4 2024 in Review

14 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q4 2024, worth a combined $19.2K — down 63% from $52K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TOIIW and 1 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 1 added.

The largest buyer was LMR Partners, opening a new position worth an estimated $25.3K. The largest seller was Walleye Capital, cutting an estimated $5.3K.

  • 14 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q4 2024, down from 15 in Q3 2024.
  • Funds reported $19.2K of The Oncology Institute Warrant stock for Q4 2024, down 63% quarter-over-quarter.
  • 1 fund opened new The Oncology Institute Warrant positions in Q4 2024 and 2 closed out, a net change of -1 holder.
  • The largest The Oncology Institute Warrant buyer in Q4 2024 was LMR Partners, an estimated $25.3K added.
  • The largest The Oncology Institute Warrant seller in Q4 2024 was Walleye Capital, an estimated $5.3K sold.

Based on aggregated 13F filings for Q4 2024.